查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197531

醫療植入物市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Medical Implants Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內 (2022-2027)，醫療植入物市場預計將以 7.35% 的複合年增長率增長。

由於供應鏈限制和患者就診次數減少，COVID-19 最初對醫療植入物市場的增長產生了重大影響。 例如，根據 2021 年 9 月在患者安全雜誌上發表的題為“COVID-19 對醫療器械報告和調查的影響”的研究，由於人與人之間接觸類型的限制，患者可能接受的治療是有限的，大流行使醫療植入物的研究更具挑戰性。 此類研究表明，COVID-19 對市場增長產生了重大影響。

促進醫療植入物市場增長的主要因素是老年人口的增加、慢性病的負擔、對美容牙科的需求增加以及醫療植入物的技術進步。

由於全球人口迅速老齡化，骨科和心血管疾病的負擔隨著年齡的增長而增加，這就產生了對醫療植入物的需求，推動了市場增長。 例如，根據世界衛生組織 (WHO) 的數據，2021 年 10 月，全球 60 歲及以上人口將佔 2050 年世界人口的 22%。 此外，同一份文件估計，到 2050 年，世界上 80% 的老年人將生活在低收入和中等收入國家。 人們發現人口老齡化會增加疾病的數量，這反過來又有助於推動全球對醫療植入物的需求。

此外，預計整容手術的增加也將在預測期內推動醫療植入物市場的增長。 例如，根據國際美容整形外科學會2020年發布的一份報告，隆胸手術位居美容手術前列，2020年進行了1,624,281例手術。 此外，根據世界衛生組織（WHO）於2020年3月發布的最新資料，估計全球約有35億人患有口腔疾病，以及可能導致牙齒脫落的嚴重牙周（牙齦）疾病。也很常見，據說影響了世界上近 10% 的人口。 因此，整容手術的興起增加了對乳房和牙科植入物的需求，推動了市場增長。 在加速醫療植入物市場發展方面發揮關鍵作用的其他一些因素包括人口可支配收入的增加、植入物領域的技術進步、更容易獲得醫療設施，以及各種事故導致肢體和器官受傷的病例增加.

然而，醫療植入物的高成本和嚴格的監管政策預計將在預測期內抑制市場。

醫療植入物市場趨勢

在醫療植入物市場中，骨科植入物部分有望佔據較大的市場份額

在醫療植入物市場中，骨科植入物部分預計將佔據很大的市場份額。 骨科植入物是用於替換缺失的關節和骨骼或支撐受損骨骼的醫療植入設備。 這些設備使用鈦合金和不銹鋼製造以增加強度，塑料塗層充當人造軟骨。 內固定是一種骨科手術，其中放置植入物以修復受損的骨骼。 它還可以矯正畸形，穩定姿勢，恢復骨骼功能。

此外，隨著 COVID-19 大流行給醫療保健系統帶來壓力，骨科手術的數量正在減少，從而限制了對醫療植入物的需求。 然而，預計未來幾年大流行後的需求將會增加。 此外，骨科植入物正在見證從傳統外科手術到現代固定和修復裝置的轉變。 由於老年人患骨質疏鬆症、骨關節炎和其他肌肉骨骼疾病的風險增加，對骨科植入物的需求顯著增加。

在2021年4月發表的一篇題為“骨折骨科植入物的微觀結構分析”的論文中，不銹鋼和鈦合金由於其優異的生物相容性、耐腐蝕性和耐用性，被認為被廣泛用作外科植入物植入材料。 他們還報告說，這些材料具有相對較高的電阻，使其適合製造生物醫學部件。

此外，主要市場參與者越來越多地推出骨科植入物，預計也將推動這一細分市場的增長。 例如，2021 年 8 月，骨科植入物公司宣布了其經 FDA 批准的腕部骨折電鍍技術 DRPx 系統，以幫助門診手術中心 (ASC) 和醫院提高財務可持續性。現已開始銷售。 2020年10月，美國美敦力推出了Adaptix Interbody System，這是一款採用Titan nanoLOCK表面技術的可導航鈦脊柱植入物。

因此，由於上述因素，預計該細分市場將在預測期內增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

北美目前在全球醫療植入物市場中佔有很大份額，預計在預測期內將遵循同樣的趨勢。 這是由於多種因素造成的，例如關節炎等疾病的發病率上升，該國因牙齒脫落而越來越多地採用美容牙科手術，完善的保險政策以及先進醫療基礎設施的可用性。

例如，根據美國牙科協會 2020 年版的數據，超過 500 萬年齡在 65 至 74 歲的美國人完全無牙，近 300 萬無牙增加。 另一方面，掉牙主要是老年人的問題。 這是因為 91% 的 20-64 歲成年人患有蛀牙，而 27% 的人未經治療。 此外，因蛀牙而導致牙齒脫落的案例也很多。 結果，牙齒逐漸鬆動並脫落。 因此，老年人牙齒脫落是牙齒疾病引起的常見問題，從而推動了老年人對種植牙的需求。

此外，向市場推出新植入物也推動了該地區的增長。 例如，2020 年 9 月，Ditron Dental USA 開始在美國開展其牙種植體產品組合的商業活動。 同樣，2022 年 6 月，ZimVie Inc. 宣布美國食品和藥物管理局批准了 T3 PRO 錐形種植體和編碼緊急癒合基台。 T3 PRO 是 ZimVie 牙種植體系列的最新成員，它建立在 T3 錐形種植體成熟的解決方案之上。 同樣，2022 年 2 月，專注於增強現實和患者特定解決方案的脊柱植入物公司 DeGen Medical, Inc. 宣布推出 Impulse AM，這是一種用於後骨間融合的 3D 打印多孔鈦植入物。 因此，在美國越來越多地推出醫療植入物將導致採用率增加，從而推動該地區的市場增長。

綜上所述，北美市場有望快速擴張。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 老齡化社會的到來和慢性病的增加
    • 對美容牙科的需求增加
    • 醫療植入物技術進步
  • 市場製約因素
    • 嚴格的監管改革
    • 醫療植入物的報銷問題和高成本
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 骨科植入物
      • 髖關節骨科手術設備
      • 聯合重建
      • 膝關節矯形器
      • 脊柱矯形器械
      • 其他產品
    • 心血管植入物
      • 起搏裝置
      • 支架
      • 心臟結構植入物
    • 眼科植入物
      • 人工晶狀體
      • 青光眼植入物
    • 種植牙
    • 面部植入物
    • 乳房植入物
    • 其他植入物
  • 按材料類型
    • 金屬生物材料
    • 高分子生物材料
    • 天然生物材料
    • 陶瓷生物材料
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Conmed Corporation
    • Globus Medical, Inc.
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Smith & Nephew PLC
    • Stryker Corporation
    • Zimmer Biomet
    • Straumann AG
    • Dentsply Sirona
    • Osstem Implant Co. Ltd
    • Henry Schein Inc.
    • Abbvie Inc.（Allergan PLC）
    • Ivoclar Vivadent Inc.
    • GC Aesthetics
    • 3M Company

第7章 市場機會與今後動向

簡介目錄
Product Code: 67164

The medical implants market is poised to grow at a CAGR of 7.35% during the forecast period (2022-2027).

COVID-19 had significantly impacted the medical implants market's growth initially due to supply chain restrictions and the reduced number of hospital visits by patients. For instance, according to the study published in Patient Safety, titled "The Impact of COVID-19 on Medical Device Reporting and Investigation" in September 2021, constraints on person-to-person contact limited the sort of treatment patients may receive, and the pandemic made researching medical implants more challenging. Such studies suggest that COVID-19 has significantly impacted the growth of the market.

The major factors contributing to the growth of the medical implants market are the increasing geriatric population, the burden of chronic diseases, increasing demand for cosmetic dentistry, and technological advancements in medical implants.

The global population is aging rapidly, so with increasing age, the burden of orthopedic and cardiovascular diseases is increasing, which creates a need for medical implants and thus drives the growth of the market. For instance, in October 2021, according to the World Health Organization (WHO), the world's population aged 60 and above will reach a share of 22% of the total world population in 2050. Furthermore, according to the same source, by 2050, 80% of the world's elderly will live in low and middle-income countries. This increase in the number of older adults is found to augment the number of disorders, which subsequently helps boost the demand for medical implants across the globe.

Furthermore, the rise in aesthetic surgeries is also expected to drive the growth of the medical implants market over the forecast period. For instance, according to the report published by the International Society of Aesthetic Plastic Surgery in 2020, breast augmentation was among the top aesthetic surgical procedures in 2020, with 1,624,281 surgeries. Moreover, according to a March 2020 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people worldwide, and severe periodontal (gum) disease, which may result in tooth loss, is also very common, with almost 10% of the global population affected. Thus, the increasing incidence of aesthetic surgeries is driving the need for breast and dental implants, thereby driving the market growth. A few other factors are playing pivotal roles in accelerating the medical implants market include the hike in disposable income among people, technological advancements in the field of implants, the availability of better medical facilities, and a growing number of cases involving damaged limbs or organs caused by various accidents.

However, the high cost of medical implants and stringent regulatory policies are expected to restrain the market for the forecast period.

Medical Implants Market Trends

Orthopedic Implants Segment is Expected to Hold a Significant Market Share in the Medical Implants Market

The orthopedic implants segment is expected to hold a significant market share in the medical implants market. Orthopedic implants are medical implant devices used to replace missing joints or bones or to support damaged bones. These devices are manufactured using titanium alloys and stainless steel for strength, while plastic coating acts as artificial cartilage. Internal fixation is a type of surgery in orthopedics involving implant implementation to repair the damaged bone. These implants also treat deformities, stabilize body posture, and restore normal skeletal function.

Furthermore, as the COVID-19 pandemic has burdened the healthcare system, there has been a decrease in the number of orthopedic surgeries performed, thereby restricting the demand for medical implants. However, demand is expected to increase post-pandemic over the coming years. Moreover, orthopedic implants have witnessed a shift from conventional surgical procedures to modern fixation and prosthetic devices. The demand for orthopedic implants has increased significantly because of the senior population's increased risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders.

The article titled "Microstructural Analysis of Fractured Orthopedic Implants" published in April 2021 reported that stainless steel and titanium alloys are widely used as implant materials in orthopedic surgery due to their good biocompatibility, corrosion resistance, and durability. It also reported that these materials are suitable for the production of bio-components used in medicine due to their relatively high tolerance.

In addition, rising launches of orthopedic implants by key market players are also expected to drive the growth of this segment. For instance, in August 2021, the Orthopaedic Implant Company launched its wrist fracture plating technology, the DRPx System, which has received Food and Drug Administration approval to enable ambulatory surgical centers (ASCs) and hospitals to improve their financial sustainability. In October 2020, Medtronic in the United States launched the Adaptix Interbody System, a navigated titanium spine implant with Titan nanoLOCK surface technology.

Therefore, this segment is expected to grow over the forecast period due to the above factors.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America currently holds a major share in the global medical implants market and is expected to follow the same trend throughout the forecast period. This is due to several factors, such as the rising incidence of diseases like arthritis, the rising adoption of cosmetic dental procedures due to tooth loss in the country, well-established insurance policies, and the availability of advanced healthcare infrastructure.

For instance, according to the American Dental Association 2020, more than 5 million United States seniors aged 65 to 74 have complete tooth loss, with nearly 3 million edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly. This is because 91 percent of adults aged 20 to 64 have dental caries, with 27 percent going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. As a result, teeth gradually loosen and fall out. Thus, the senior dental loss is a common problem due to dental diseases, thereby driving the demand for dental implants in the geriatric population. ​

Furthermore, the introduction of new implants into the market is also driving growth in the region. For instance, in September 2020, Ditron Dental USA launched its commercial operations in the United States for its dental implant portfolio. Likewise, in June 2022, ZimVie Inc. announced that the Food and Drug Administration-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the United States. The T3 PRO is the newest addition to ZimVie's family of dental implants and builds on the proven solutions of the T3 Tapered Implant. Similarly, in February 2022, DeGen Medical, Inc., a spinal implant company specializing in augmented reality and patient-specific solutions, launched Impulse AM, a 3D-printed porous titanium implant for posterior interbody fusion. Therefore, the rise in the launch of medical implants in the United States will lead to increased adoption, thereby driving market growth in this region.

Hence, owing to the abovementioned factors, the North American market is expected to drive swiftly.

Medical Implants Market Competitor Analysis

The medical implants market is fragmented and consists of several major players. In terms of market share, a few major players dominate the market. Some prominent players are vigorously making acquisitions of other companies to consolidate their market positions globally. These major global medical implants market companies include Abbott Laboratories, 3M Company, Strauman AG, Dentsply Sirona, Johnson & Johnson Limited, Stryker, and Boston Scientific Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Burden of Chronic Diseases
    • 4.2.2 Increasing Demand for Cosmetic Dentistry
    • 4.2.3 Technological Advancements in the Medical Implants
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Reforms
    • 4.3.2 Reimbursement Issues and High Cost of Medical Implants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Orthopedic Implants
      • 5.1.1.1 Hip Orthopaedic Device
      • 5.1.1.2 Joint Reconstruction
      • 5.1.1.3 Knee Orthopedic Devices
      • 5.1.1.4 Spine Orthopedic Devices
      • 5.1.1.5 Other Products
    • 5.1.2 Cardiovascular Implants
      • 5.1.2.1 Pacing devices
      • 5.1.2.2 Stents
      • 5.1.2.3 Structural Cardiac Implants
    • 5.1.3 Ophthalmic implants
      • 5.1.3.1 Intraocular lens
      • 5.1.3.2 Glaucoma Implants
    • 5.1.4 Dental Implants
    • 5.1.5 Facial Implants
    • 5.1.6 Breast Implants
    • 5.1.7 Other Implants
  • 5.2 By Type of Material
    • 5.2.1 Metallic Biomaterial
    • 5.2.2 Polymers Biomaterial
    • 5.2.3 Natural Biomaterial
    • 5.2.4 Ceramic Biomaterial
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biotronik SE & Co. KG
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Cardinal Health, Inc.
    • 6.1.5 Conmed Corporation
    • 6.1.6 Globus Medical, Inc.
    • 6.1.7 Integra Lifesciences Holdings Corporation
    • 6.1.8 Johnson & Johnson
    • 6.1.9 Smith & Nephew PLC
    • 6.1.10 Stryker Corporation
    • 6.1.11 Zimmer Biomet
    • 6.1.12 Straumann AG
    • 6.1.13 Dentsply Sirona
    • 6.1.14 Osstem Implant Co. Ltd
    • 6.1.15 Henry Schein Inc.
    • 6.1.16 Abbvie Inc. (Allergan PLC)
    • 6.1.17 Ivoclar Vivadent Inc.
    • 6.1.18 GC Aesthetics
    • 6.1.19 3M Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS